Molecular mechanisms required for the maintenance of the gram-negative outer membrane
维持革兰氏阴性外膜所需的分子机制
基本信息
- 批准号:10159193
- 负责人:
- 金额:$ 40.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-06-01 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:ATP-binding cassette transportAntibioticsArchitectureBacteriaBindingBinding ProteinsBiochemicalBiological AssayCell DeathCellsCommunicable DiseasesComplexDataDetergentsEncapsulatedEnvironmentEnvironmental ProtectionEnvironmental Risk FactorEnzymesEscherichia coliGenerationsGeneticGlycerophospholipidsGram-Negative BacteriaGrowthHandHumanIn VitroInfectionInnate Immune SystemInvestigationKnowledgeLipid ALipid BindingLipidsLipopolysaccharidesLipoproteinsMaintenanceMembraneMembrane LipidsModificationMolecularMulti-Drug ResistanceMutationOrganismPathway interactionsPeptidoglycanPhospholipases APhospholipidsProteinsReportingResearchRoleSalmonellaSiteStressStructureSubstrate SpecificitySurfaceSystemVirulenceanterograde transportantimicrobialantimicrobial peptidebasecell envelopecrosslinkenvironmental stressorfightingin vivolipophilicitymembrane assemblymigrationmonolayernovelnovel therapeuticspathogenpathogenic bacteriaperiplasmpreventprotein protein interactionretrograde transport
项目摘要
Abstract
The bacterial cell envelope is a remarkable and complex structure that guards bacteria from their
surrounding environment. A defining feature of gram-negative bacteria is the presence of an outer membrane
(OM) that encapsulates the peptidoglycan layer of these organisms. While the inner membrane (IM) is
composed of glycerophospholipids (GPLs), the OM is a bilayer with extreme lipid asymmetry with GPL
confined to the inner leaflet and lipopolysaccharide (LPS) localized to the outer leaflet. This unique membrane
organization affords gram-negative bacteria protection from large polar molecules, as well as lipophilic
compounds, serving as an essential innate barrier to a variety of antibiotics.
However, once assembled, environmental factors can disrupt the LPS monolayer resulting in shedding of
LPS, and as a consequence, migration of GPLs from the inner leaflet to the outer leaflet of the OM. Extensive
formation of GPL rafts at the bacterial surface results in the loss of barrier function which leads to cell death.
To prevent this, the cell must maintain the OM asymmetry even under extreme environmental stress. The
overall objective of this application is to investigate the molecular mechanisms required for maintenance of
OM asymmetry, including the role of the recently identified Mla retrograde GPL transport system. We will also
investigate two additional systems, Pqi and Yeb systems, that may also serve in GPL transport. All three
systems (Mla, Pqi, and Yeb) are highly conserved across Gram-negative bacteria and disruption of OM
maintenance machinery has been shown to result in decreased virulence for many pathogens. The Specific
Aims of the current proposal are: (1) structure and functional analysis of Mla lipid binding proteins; (2) overall
architecture and protein-protein interactions of Mla components; and (3) investigation of lipid binding by GPL
transport systems in whole bacteria. Completion of the Aims will fill major gaps towards understanding
maintenance of OM asymmetry and provide new avenues for the generation of novel antimicrobials.
摘要
细菌的细胞被膜是一种非凡而复杂的结构,它保护细菌免受它们的
周边环境革兰氏阴性菌的一个明显特征是存在外膜
(OM)包裹着这些生物体的肽聚糖层。内膜(IM)
OM由甘油磷脂(GPL)组成,是一种与GPL极不对称的双层脂质
局限于内小叶,脂多糖(LPS)局限于外小叶。这种独特的膜
组织提供革兰氏阴性菌保护免受大极性分子,以及亲脂性
化合物,作为一个基本的先天屏障,以各种抗生素。
然而,一旦组装,环境因素可以破坏LPS单层,导致LPS脱落。
LPS,并因此导致GPL从OM的内瓣叶迁移至外瓣叶。广泛
GPL筏在细菌表面的形成导致屏障功能的丧失,从而导致细胞死亡。
为了防止这种情况,即使在极端的环境压力下,细胞也必须保持OM不对称性。的
本申请的总体目标是研究维持
OM不对称性,包括最近发现的Mla逆行GPL运输系统的作用。我们还将
研究另外两个系统,Pqi和Yeb系统,它们也可能用于GPL传输。所有三
系统(Mla,Pqi和Yeb)在革兰氏阴性菌中高度保守,OM破坏
已显示维持机制导致许多病原体的毒力降低。具体
本研究的主要目的是:(1)Mla脂质结合蛋白的结构和功能分析;(2)Mla脂质结合蛋白的整体结构和功能分析;(3)Mla脂质结合蛋白的结构和功能分析;(4)Mla脂质结合蛋白的结构和功能分析。
Mla组分的结构和蛋白质-蛋白质相互作用;(3)通过GPL研究脂质结合
整个细菌的运输系统。目标的完成将填补理解方面的主要空白
维持OM不对称性,并为产生新型抗菌剂提供新的途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Stephen Trent其他文献
Michael Stephen Trent的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Stephen Trent', 18)}}的其他基金
The role of cardiolipin in the biogenesis of the Gram-negative bacterial cell envelope
心磷脂在革兰氏阴性细菌细胞包膜生物发生中的作用
- 批准号:
10731444 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Synthesis and transport of outer membrane components across the Gram-negative cell envelope
外膜成分的合成和跨革兰氏阴性细胞包膜的运输
- 批准号:
10680968 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumannii
多重耐药病原体鲍曼不动杆菌的细胞包膜
- 批准号:
10113527 - 财政年份:2020
- 资助金额:
$ 40.96万 - 项目类别:
The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumannii
多重耐药病原体鲍曼不动杆菌的细胞包膜
- 批准号:
10542396 - 财政年份:2020
- 资助金额:
$ 40.96万 - 项目类别:
The Cell Envelope of the Multi-Drug Resistant Pathogen Acinetobacter baumannii
多重耐药病原体鲍曼不动杆菌的细胞包膜
- 批准号:
10328269 - 财政年份:2020
- 资助金额:
$ 40.96万 - 项目类别:
Molecular mechanisms required for the maintenance of the gram-negative outer membrane
维持革兰氏阴性外膜所需的分子机制
- 批准号:
10403653 - 财政年份:2018
- 资助金额:
$ 40.96万 - 项目类别:
Molecular mechanisms required for the maintenance of the gram-negative outer membrane
维持革兰氏阴性外膜所需的分子机制
- 批准号:
9917747 - 财政年份:2018
- 资助金额:
$ 40.96万 - 项目类别:
Development of a novel vaccine platform: Surface Antigen/Adjuvant Vaccine Engineering (SAAVE)
新型疫苗平台的开发:表面抗原/佐剂疫苗工程(SAAVE)
- 批准号:
9899172 - 财政年份:2017
- 资助金额:
$ 40.96万 - 项目类别:
Rethinking the barrier: How a Gram-negative bacterium alters its surface to become multidrug resistant
重新思考屏障:革兰氏阴性细菌如何改变其表面以产生多重耐药性
- 批准号:
9102680 - 财政年份:2015
- 资助金额:
$ 40.96万 - 项目类别:
相似海外基金
Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
- 批准号:
2902098 - 财政年份:2024
- 资助金额:
$ 40.96万 - 项目类别:
Studentship
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
- 批准号:
EP/Z533026/1 - 财政年份:2024
- 资助金额:
$ 40.96万 - 项目类别:
Research Grant
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
- 批准号:
BB/Y004035/1 - 财政年份:2024
- 资助金额:
$ 40.96万 - 项目类别:
Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
- 批准号:
FT230100468 - 财政年份:2024
- 资助金额:
$ 40.96万 - 项目类别:
ARC Future Fellowships
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 40.96万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 40.96万 - 项目类别:
Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
- 批准号:
MR/Y033809/1 - 财政年份:2024
- 资助金额:
$ 40.96万 - 项目类别:
Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
- 批准号:
494853 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
- 批准号:
2884862 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
- 批准号:
2904356 - 财政年份:2023
- 资助金额:
$ 40.96万 - 项目类别:
Studentship














{{item.name}}会员




